$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
达沙替尼要吃多长时间
2025-10-19 11:44:20
Check Details
达沙替尼的作用机制
2025-10-19 11:44:20
Check Details
达沙替尼的服用剂量是多少
2025-10-19 11:44:20
Check Details
达沙替尼剂量增加需要什么条件
2025-10-19 11:44:20
Check Details
达沙替尼服用过量怎么办
2025-10-19 11:44:20
Check Details
达沙替尼在肝、肾损伤的患者中需要修改剂量吗?
2025-10-19 11:44:20
Check Details
普纳替尼(Ponatinib)说明书
2025-10-19 11:44:20
Check Details
服用达沙替尼QT间期如何变化
2025-10-19 11:44:20
Check Details
达沙替尼的药效能维持多久
2025-10-19 11:44:20
Check Details
达沙替尼服用期间的注意事项
2025-10-19 11:44:20
Check Details
达沙替尼的疗效分析
2025-10-19 11:44:20
Check Details
达沙替尼对白血病有没有作用
2025-10-19 11:44:20
Check Details
1
2
...
4446
4447
4448
4449
4450
4451
4452
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
2
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
3
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
4
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
5
Daraxonrasib Pregnancy, Lactation and Contraception Safety
6
Afatinib Side Effects and Safety Management
7
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
8
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis
9
Key points for drug monitoring of Molotinib in bone marrow fibrosis
10
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
11
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
12
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data